Takeda Pharmaceutical
TAK
#491
Rank
NZ$81.93 B
Marketcap
NZ$24.62
Share price
0.28%
Change (1 day)
7.04%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2025 (TTM): NZ$50.91 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is NZ$51.12 Billion. In 2024 the company made a revenue of NZ$53.05 Billion an increase over the revenue in the year 2023 that were of NZ$46.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$50.91 B-4.02%
2024 NZ$53.05 B14.27%
2023 NZ$46.42 B-0.54%
2022 NZ$46.67 B3.14%
2021 NZ$45.25 B8.13%
2020 NZ$41.85 B-5.07%
2019 NZ$44.09 B83.16%
2018 NZ$24.07 B7.44%
2017 NZ$22.40 B-2.87%
2016 NZ$23.06 B4.03%
2015 NZ$22.17 B8%
2014 NZ$20.53 B1.32%
2013 NZ$20.26 B-13.42%
2012 NZ$23.40 B-1.17%
2011 NZ$23.68 B11.02%
2010 NZ$21.33 B-0.29%
2009 NZ$21.39 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
NZ$159.54 B 212.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.28 B 60.94%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$108.70 B 112.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$97.60 B 90.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ$3.98 B-92.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$6.85 B-86.60%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$62.28 B 21.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$73.32 B 43.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$111.21 B 117.53%๐Ÿ‡บ๐Ÿ‡ธ USA